Prior SARS-CoV-2 infection enhances Johnson and Johnson Ad26.COV2.S vaccine immunogenicity The Medical News, 30 Jul 2021 A new study reports that the single-dose Johnson and Johnson Ad26.COV2.S vaccine against coronavirus disease 2019 (COVID-19…